SABRE and the Opening of Bone Health’s Next Chapter - Mary Bouxsein, Ph.D.

In this pivotal episode of The Bone Health Basement Tapes, host Peter Bianco is joined by Dr. Mary Bouxsein—Professor of Orthopedic Surgery at Harvard Medical School and a central leader behind the SABRE initiative—alongside Dr. Shannon Carpenter, founder of The Bone Health Clinic.At the center of the conversation is SABRE (Study to Advance Bone Mineral Density as a Regulatory Endpoint), a landmark effort that has reshaped the future of osteoporosis drug development. Drawing on data from over 50 clinical trials and more than 160,000 patients, SABRE demonstrated that changes in bone mineral density (BMD) can reliably predict fracture risk reduction—paving the way for smaller, faster, and more efficient clinical trials.But this episode goes far beyond regulatory science.Together, the group explores why this moment may represent a true “Big Bang” for bone health—a long-awaited inflection point where innovation, investment, and infrastructure may finally converge. With shorter and less costly trials, the barriers that have stalled new drug development for years may begin to fall, unlocking a new wave of therapies in a field that has seen limited progress since 2019.From the clinical front lines, Dr. Carpenter brings a powerful perspective on the everyday reality of fragility fractures—still vastly underdiagnosed and undertreated despite the availability of effective therapies. The discussion highlights a critical gap: up to 90% of patients remain untreated even after a fracture, underscoring that the challenge is not just innovation, but implementation.The episode also dives into the broader system implications:How shifting trial design may move the bottleneck from measurement to patient identificationThe emerging role of opportunistic imaging and AI in early detectionThe growing strain on DXA capacity and the need for alternative screening pathwaysThe lack of infrastructure and trained providers to manage newly identified patientsThe importance of earlier intervention—well before age 65Perhaps most importantly, the conversation reframes osteoporosis itself—from an inevitable part of aging to a preventable and treatable condition. As Dr. Bouxsein emphasizes, bone health is foundational to longevity: without mobility, healthspan collapses.The episode closes with a forward-looking vision: a future where bone health is assessed earlier, treated proactively, and fully integrated into mainstream healthcare—supported by aligned incentives, better education, and increased public awareness.If SABRE reaches its full potential, this may be the moment the field finally shifts—from reacting to fractures to preventing them.